Insurers, labs point fingers over COVID-19 test coverage, prices

An AHIP study of claims data is the latest volley in a debate over the cost of coronavirus diagnostics and who ultimately foots the bill. A clinical lab trade group blames “murky” tri-agency guidance for coverage denials and high costs.

Show CommentsClose Comments

Leave a comment